Large language models and rheumatology: are we there yet?

dc.contributor.authorBenavent, Diego
dc.contributor.authorMadrid García, Alfredo
dc.date.accessioned2025-06-20T10:56:02Z
dc.date.available2025-06-20T10:56:02Z
dc.date.issued2024-09-18
dc.date.updated2025-06-11T11:12:38Z
dc.description.abstractThe last 2 years have marked the beginning of a golden age for natural language processing in medicine. The arrival of large language models (LLMs) and multimodal models have raised new opportunities and challenges for research and clinical practice. In rheumatology, a specialty rich in data and requiring complex decision-making, the use of these tools may transform diagnostic procedures, improve patient interaction and simplify data management, leading to more personalized and efficient healthcare outcomes. The objective of this article is to present an overview of the status of LLMs in the field of rheumatology while discussing some of the challenges ahead in this area of great potential. What does this research mean for patients?Large language models (LLMs) present both new opportunities and challenges for research and clinical practice in rheumatology. Although these models hold considerable potential, it is essential for rheumatologists to become familiar with their fundamental principles and recognize their limitations before incorporating them into clinical decision-making. Understanding how LLMs are capable of generating fresh answers and how they are trained is vital for maximizing the benefits while mitigating the risks associated with their use in research and patient care. Therefore, this study aims to introduce the basic principles of LLMs for rheumatologists in order to understand their probabilistic nature and mistakes, discuss some potential applications of natural language processing (NLP), explore the utility of training specific rheumatology-related LLMs, and examine the ethical dilemmas associated with their use. Based on the fast and continuous evolution of the NLP field, it is likely that recommendations guidelines or points to consider on the ethical use of LLMs in rheumatology will be essential to evaluate their impact on clinical practice.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2514-1775
dc.identifier.pmid40256630
dc.identifier.urihttps://hdl.handle.net/2445/221677
dc.language.isoeng
dc.publisherOxford University Press (OUP)
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1093/rap/rkae119
dc.relation.ispartofRheumatology Advances in Practice, 2024, vol. 9, num. 2
dc.relation.urihttps://doi.org/10.1093/rap/rkae119
dc.rightscc-by (c) Benavent et al., 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationTractament del llenguatge natural (Informàtica)
dc.subject.classificationReumatologia
dc.subject.classificationDiagnòstic
dc.subject.otherNatural language processing (Computer science)
dc.subject.otherRheumatology
dc.subject.otherDiagnosis
dc.titleLarge language models and rheumatology: are we there yet?
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
rkae119.pdf
Mida:
1.08 MB
Format:
Adobe Portable Document Format